Artelo Financial Statements From 2010 to 2026

ARTL Stock  USD 1.47  0.10  7.30%   
Artelo Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Artelo Biosciences' valuation are provided below:
Market Capitalization
3.5 M
Earnings Share
(19.50)
There are over one hundred nineteen available fundamental signals for Artelo Biosciences, which can be analyzed over time and compared to other ratios. We recommend to validate Artelo Biosciences' prevailing fundamental drivers against the all of the trends between 2010 and 2026. The value of Market Cap is estimated to slide to about 4.8 M. The Enterprise Value is projected to slide to about 1.2 M
Check Artelo Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Artelo Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 2.5 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 6.9. Artelo financial statements analysis is a perfect complement when working with Artelo Biosciences Valuation or Volatility modules.
  
Build AI portfolio with Artelo Stock
Check out the analysis of Artelo Biosciences Correlation against competitors.
For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.

Artelo Biosciences Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets6.3 M5.4 M4.4 M
Slightly volatile
Cash2.6 M2.7 M1.9 M
Slightly volatile
Cash And Short Term Investments4.8 M2.7 M3.3 M
Slightly volatile
Common Stock Total Equity6.3 K4.5 K6.5 K
Pretty Stable
Common Stock Shares Outstanding3.9 M3.7 M858.5 K
Slightly volatile
Liabilities And Stockholders Equity6.3 M5.4 M4.4 M
Slightly volatile
Other Stockholder Equity64.2 M61.2 M19.9 M
Slightly volatile
Total Current AssetsM2.9 M3.4 M
Slightly volatile
Common Stock2.6 K2.7 KK
Pretty Stable
Total Current Liabilities2.1 MM639.8 K
Slightly volatile
Accounts PayableM1.9 M570.2 K
Slightly volatile
Capital Surpluse12.4 M11.8 M5.3 M
Slightly volatile
Property Plant And Equipment Net119.5 K113.8 K30 K
Slightly volatile
Property Plant And Equipment Gross119.5 K113.8 K27.7 K
Slightly volatile
Capital Stock2.6 K2.7 K10.2 K
Slightly volatile
Short and Long Term Debt Total57 K93.6 K87.1 K
Slightly volatile

Artelo Biosciences Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative2.5 M4.7 M1.9 M
Slightly volatile
Other Operating Expenses12.2 M11.6 M4.2 M
Slightly volatile
Total Operating Expenses12.2 M11.6 M4.2 M
Slightly volatile
Research Development7.2 M6.9 M2.8 M
Slightly volatile
Reconciled Depreciation441358329
Slightly volatile

Artelo Biosciences Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash Flow2.6 M2.7 M1.9 M
Slightly volatile
Begin Period Cash Flow3.2 M3.2 M2.1 M
Slightly volatile
Depreciation435358347
Slightly volatile
Stock Based Compensation951.9 K940.7 K520 K
Slightly volatile
Issuance Of Capital Stock95.8 K100.8 K1.9 M
Very volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables472.2 K482.5 K436.7 K
Pretty Stable
Capex To Depreciation2.8 K2.6 K1.5 K
Slightly volatile
Cash Per Share0.620.6526.6238
Very volatile
Income Quality0.70.760.8523
Pretty Stable
Intangibles To Total Assets0.30.50.297
Very volatile
Net Debt To EBITDA0.240.250.7314
Slightly volatile
Current Ratio1.231.38.6608
Pretty Stable
Debt To Equity0.03440.03280.0117
Slightly volatile
Capex Per Share59.0956.2832.5621
Slightly volatile
Average Receivables8.5 K5.1 K7.8 K
Slightly volatile
Interest Debt Per Share0.03530.03710.2033
Slightly volatile
Debt To Assets0.02090.01990.009
Slightly volatile
Ebt Per Ebit0.750.870.9351
Slightly volatile
Long Term Debt To Capitalization0.00130.00140.004
Slightly volatile
Total Debt To Capitalization0.03320.03160.0114
Slightly volatile
Debt Equity Ratio0.03440.03280.0117
Slightly volatile
Quick Ratio1.231.38.6614
Pretty Stable
Cash Ratio1.441.526.5131
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.021.381.245
Slightly volatile
Debt Ratio0.02090.01990.009
Slightly volatile

Artelo Biosciences Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.8 M7.4 M5.7 M
Slightly volatile

Artelo Fundamental Market Drivers

Artelo Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Artelo Biosciences Financial Statements

Artelo Biosciences investors utilize fundamental indicators, such as revenue or net income, to predict how Artelo Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Artelo Biosciences is a strong investment it is important to analyze Artelo Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Artelo Biosciences' future performance. For an informed investment choice regarding Artelo Stock, refer to the following important reports:
Check out the analysis of Artelo Biosciences Correlation against competitors.
For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Artelo Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(19.50)
Return On Assets
(1.36)
Return On Equity
(4.36)
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Artelo Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Artelo Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Artelo Biosciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.